TreeWAS – Variant ID: rs8192579

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
J40-J47 Chronic lower respiratory diseases	0.000	0.000	1.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
J45 Asthma	0.000	0.000	1.000
J47 Bronchiectasis	0.000	0.000	1.000
J33 Nasal polyp	0.000	0.001	0.999
Chapter X Diseases of the respiratory system	0.000	0.001	0.999
J30-J39 Other diseases of upper respiratory tract	0.000	0.001	0.999
J33.0 Polyp of nasal cavity	0.000	0.003	0.997
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.003	0.997
M06.9 Rheumatoid arthritis, unspecified	0.000	0.003	0.997
J33.9 Nasal polyp, unspecified	0.000	0.008	0.992
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.011	0.989
L40.0 Psoriasis vulgaris	0.975	0.025	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.046	0.954
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.061	0.939
J84 Other interstitial pulmonary diseases	0.000	0.071	0.929
J00-J06 Acute upper respiratory infections	0.000	0.080	0.920
J44 Other chronic obstructive pulmonary disease	0.000	0.080	0.920
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.088	0.912
E10.9 Without complications	0.000	0.093	0.907
J03 Acute tonsillitis	0.000	0.095	0.905
E10 Insulin-dependent diabetes mellitus	0.000	0.096	0.904
J03.9 Acute tonsillitis, unspecified	0.000	0.106	0.894
E10.3 With ophthalmic complications	0.000	0.110	0.890
T36-T50 Poisoning by drugs, medicaments and biological substances	0.876	0.124	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.873	0.127	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.134	0.866
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.135	0.865
J33.8 Other polyp of sinus	0.000	0.136	0.864
J45.0 Predominantly allergic asthma	0.000	0.136	0.864
T39.1 4-Aminophenol derivatives	0.862	0.138	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.139	0.861
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.144	0.856
J30 Vasomotor and allergic rhinitis	0.000	0.157	0.842
J42 Unspecified chronic bronchitis	0.000	0.161	0.839
L40-L45 Papulosquamous disorders	0.838	0.161	0.001
L40.8 Other psoriasis	0.837	0.163	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.828	0.172	0.000
L40.1 Generalised pustular psoriasis	0.819	0.181	0.000
E10.4 With neurological complications	0.000	0.188	0.812
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.196	0.804
J60-J70 Lung diseases due to external agents	0.000	0.200	0.800
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.798	0.202	0.000
M06 Other rheumatoid arthritis	0.167	0.210	0.623
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.784	0.216	0.000
Chapter V Mental and behavioural disorders	0.779	0.221	0.000
F30-F39 Mood [affective] disorders	0.777	0.223	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.771	0.229	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.236	0.764
J32 Chronic sinusitis	0.000	0.240	0.760
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.756	0.244	0.000
F41 Other anxiety disorders	0.753	0.247	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.750	0.250	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.748	0.252	0.000
# Top node	0.731	0.255	0.014
J46 Status asthmaticus	0.000	0.255	0.745
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.743	0.257	0.000
J81 Pulmonary oedema	0.000	0.259	0.741
J40 Bronchitis, not specified as acute or chronic	0.000	0.259	0.741
F31 Bipolar affective disorder	0.739	0.261	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.266	0.734
J37 Chronic laryngitis and laryngotracheitis	0.000	0.266	0.734
Chapter XII Diseases of the skin and subcutaneous tissue	0.729	0.268	0.003
F60-F69 Disorders of adult personality and behaviour	0.731	0.269	0.000
E10.1 With ketoacidosis	0.000	0.270	0.730
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.729	0.271	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.728	0.271	0.001
J30.1 Allergic rhinitis due to pollen	0.000	0.276	0.724
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.722	0.278	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.000	0.280	0.720
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.718	0.282	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.717	0.283	0.000
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
J41 Simple and mucopurulent chronic bronchitis	0.000	0.283	0.717
J45.8 Mixed asthma	0.000	0.283	0.717
J45.1 Nonallergic asthma	0.000	0.283	0.717
J33.1 Polypoid sinus degeneration	0.000	0.283	0.717
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.285	0.715
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.285	0.715
F30 Manic episode	0.711	0.289	0.000
J01 Acute sinusitis	0.000	0.294	0.706
M05-M14 Inflammatory polyarthropathies	0.447	0.296	0.257
Chapter VI Diseases of the nervous system	0.702	0.298	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.701	0.299	0.000
J39 Other diseases of upper respiratory tract	0.000	0.308	0.692
T42.4 Benzodiazepines	0.692	0.308	0.000
F33 Recurrent depressive disorder	0.691	0.309	0.000
F60 Specific personality disorders	0.686	0.314	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.000	0.316	0.684
J32.0 Chronic maxillary sinusitis	0.000	0.322	0.678
E10-E14 Diabetes mellitus	0.015	0.323	0.662
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.674	0.326	0.000
F41.2 Mixed anxiety and depressive disorder	0.672	0.328	0.000
G20-G26 Extrapyramidal and movement disorders	0.672	0.328	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.000	0.328	0.671
M07.3 Other psoriatic arthropathies	0.664	0.330	0.006
J04 Acute laryngitis and tracheitis	0.000	0.332	0.668
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.666	0.334	0.000
J84.8 Other specified interstitial pulmonary diseases	0.000	0.334	0.666
J84.0 Alveolar and parietoalveolar conditions	0.000	0.334	0.666
L42 Pityriasis rosea	0.665	0.335	0.001
T39.0 Salicylates	0.665	0.335	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.661	0.338	0.001
T47.1 Other antacids and anti-gastric-secretion drugs	0.660	0.340	0.000
J36 Peritonsillar abscess	0.000	0.341	0.659
Chapter IV Endocrine, nutritional and metabolic diseases	0.039	0.341	0.620
F31.9 Bipolar affective disorder, unspecified	0.658	0.342	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.656	0.343	0.001
S32 Fracture of lumbar spine and pelvis	0.654	0.346	0.000
T43.2 Other and unspecified antidepressants	0.654	0.346	0.000
Q50-Q56 Congenital malformations of genital organs	0.651	0.348	0.001
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.349	0.651
E10.5 With peripheral circulatory complications	0.000	0.351	0.649
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.351	0.649
J03.8 Acute tonsillitis due to other specified organisms	0.000	0.351	0.649
J03.0 Streptococcal tonsillitis	0.000	0.351	0.649
M07 Psoriatic and enteropathic arthropathies	0.538	0.352	0.111
E10.8 With unspecified complications	0.000	0.352	0.648
E10.7 With multiple complications	0.000	0.352	0.648
E10.6 With other specified complications	0.000	0.352	0.648
E10.2 With renal complications	0.000	0.352	0.648
E10.0 With coma	0.000	0.352	0.648
F41.1 Generalised anxiety disorder	0.644	0.356	0.000
F30.0 Hypomania	0.642	0.358	0.000
F44 Dissociative [conversion] disorders	0.641	0.359	0.000
E00-E07 Disorders of thyroid gland	0.004	0.361	0.635
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.363	0.636
S10-S19 Injuries to the neck	0.633	0.367	0.000
T42.1 Iminostilbenes	0.633	0.367	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.633	0.367	0.000
Q80-Q89 Other congenital malformations	0.631	0.368	0.001
J30.3 Other allergic rhinitis	0.000	0.370	0.630
E03 Other hypothyroidism	0.001	0.371	0.628
Q20-Q28 Congenital malformations of the circulatory system	0.629	0.371	0.001
F45 Somatoform disorders	0.629	0.371	0.000
G20 Parkinson's disease	0.628	0.372	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.628	0.372	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.628	0.372	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.628	0.372	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.628	0.372	0.000
T36 Poisoning by systemic antibiotics	0.628	0.372	0.000
F60.9 Personality disorder, unspecified	0.627	0.373	0.000
F31.8 Other bipolar affective disorders	0.627	0.373	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.626	0.374	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.626	0.374	0.000
T39.4 Antirheumatics, not elsewhere classified	0.626	0.374	0.000
T39.2 Pyrazolone derivatives	0.626	0.374	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.376	0.624
M06.0 Seronegative rheumatoid arthritis	0.075	0.378	0.547
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.620	0.380	0.000
L50-L54 Urticaria and erythema	0.616	0.383	0.001
J32.4 Chronic pansinusitis	0.000	0.383	0.617
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.440	0.392	0.168
G24 Dystonia	0.604	0.396	0.000
G50-G59 Nerve, nerve root and plexus disorders	0.604	0.396	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.396	0.604
J30.0 Vasomotor rhinitis	0.000	0.396	0.604
E05 Thyrotoxicosis [hyperthyroidism]	0.001	0.397	0.602
L44 Other papulosquamous disorders	0.601	0.398	0.001
L41 Parapsoriasis	0.601	0.398	0.001
L45 Papulosquamous disorders in diseases classified elsewhere	0.601	0.398	0.001
G70-G73 Diseases of myoneural junction and muscle	0.601	0.399	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.597	0.402	0.001
F34 Persistent mood [affective] disorders	0.597	0.402	0.000
F32 Depressive episode	0.597	0.403	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.595	0.404	0.001
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.596	0.404	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.593	0.406	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.593	0.406	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.593	0.406	0.000
T42.3 Barbiturates	0.593	0.406	0.000
T42.2 Succinimides and oxazolidinediones	0.593	0.406	0.000
T42.0 Hydantoin derivatives	0.593	0.406	0.000
S32.4 Fracture of acetabulum	0.593	0.407	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.591	0.409	0.000
J30.4 Allergic rhinitis, unspecified	0.000	0.410	0.590
F42 Obsessive-compulsive disorder	0.589	0.411	0.000
F40 Phobic anxiety disorders	0.584	0.416	0.000
J69 Pneumonitis due to solids and liquids	0.000	0.416	0.583
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.583	0.417	0.000
Q21 Congenital malformations of cardiac septa	0.579	0.420	0.000
S40-S49 Injuries to the shoulder and upper arm	0.579	0.421	0.000
G90-G99 Other disorders of the nervous system	0.579	0.421	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.421	0.578
Q51 Congenital malformations of uterus and cervix	0.578	0.422	0.000
F41.9 Anxiety disorder, unspecified	0.578	0.422	0.000
F69 Unspecified disorder of adult personality and behaviour	0.577	0.423	0.000
F60.3 Emotionally unstable personality disorder	0.577	0.423	0.000
T51 Toxic effect of alcohol	0.577	0.423	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.576	0.424	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.576	0.424	0.000
F30.9 Manic episode, unspecified	0.574	0.426	0.000
J70 Respiratory conditions due to other external agents	0.000	0.426	0.574
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.000	0.426	0.574
J67 Hypersensitivity pneumonitis due to organic dust	0.000	0.426	0.574
J66 Airway disease due to specific organic dust	0.000	0.426	0.574
J63 Pneumoconiosis due to other inorganic dusts	0.000	0.426	0.574
J62 Pneumoconiosis due to dust containing silica	0.000	0.426	0.574
J65 Pneumoconiosis associated with tuberculosis	0.000	0.426	0.574
J64 Unspecified pneumoconiosis	0.000	0.426	0.574
J60 Coalworker's pneumoconiosis	0.000	0.426	0.574
Q38-Q45 Other congenital malformations of the digestive system	0.572	0.427	0.001
T38.9 Other and unspecified hormone antagonists	0.572	0.427	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.572	0.427	0.000
T38.7 Androgens and anabolic congeners	0.572	0.427	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.572	0.427	0.000
T38.5 Other oestrogens and progestogens	0.572	0.427	0.000
T38.4 Oral contraceptives	0.572	0.427	0.000
T38.2 Antithyroid drugs	0.572	0.427	0.000
T38.1 Thyroid hormones and substitutes	0.572	0.427	0.000
T38.0 Glucocorticoids and synthetic analogues	0.572	0.427	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.571	0.429	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.571	0.429	0.000
J90-J94 Other diseases of pleura	0.000	0.432	0.568
M06.8 Other specified rheumatoid arthritis	0.120	0.433	0.447
M06.4 Inflammatory polyarthropathy	0.120	0.433	0.447
M06.2 Rheumatoid bursitis	0.120	0.433	0.447
M06.1 Adult-onset Still's disease	0.120	0.433	0.447
F33.1 Recurrent depressive disorder, current episode moderate	0.566	0.434	0.000
Q60-Q64 Congenital malformations of the urinary system	0.561	0.438	0.001
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.560	0.440	0.000
F80-F89 Disorders of psychological development	0.560	0.440	0.000
G56 Mononeuropathies of upper limb	0.559	0.441	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.559	0.441	0.000
G51 Facial nerve disorders	0.559	0.441	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.558	0.441	0.000
F70-F79 Mental retardation	0.558	0.441	0.000
S31 Open wound of abdomen, lower back and pelvis	0.559	0.441	0.000
F38 Other mood [affective] disorders	0.557	0.443	0.000
F39 Unspecified mood [affective] disorder	0.557	0.443	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.556	0.444	0.000
F48 Other neurotic disorders	0.553	0.447	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.552	0.448	0.000
J01.9 Acute sinusitis, unspecified	0.000	0.448	0.552
F31.0 Bipolar affective disorder, current episode hypomanic	0.551	0.449	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.550	0.450	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.550	0.450	0.000
S32.40 Fracture of acetabulum (closed)	0.550	0.450	0.000
J95-J99 Other diseases of the respiratory system	0.000	0.451	0.549
Chapter XXII Codes for special purposes	0.536	0.454	0.009
J32.3 Chronic sphenoidal sinusitis	0.000	0.455	0.545
J37.0 Chronic laryngitis	0.000	0.456	0.544
S20-S29 Injuries to the thorax	0.544	0.456	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.540	0.456	0.004
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.539	0.458	0.004
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.542	0.458	0.000
Q00-Q07 Congenital malformations of the nervous system	0.541	0.458	0.001
F41.8 Other specified anxiety disorders	0.540	0.460	0.000
F41.3 Other mixed anxiety disorders	0.540	0.460	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.539	0.460	0.000
T00-T07 Injuries involving multiple body regions	0.538	0.462	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.538	0.462	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.538	0.462	0.000
T47.7 Emetics	0.538	0.462	0.000
T47.6 Antidiarrhoeal drugs	0.538	0.462	0.000
T47.5 Digestants	0.538	0.462	0.000
T47.4 Other laxatives	0.538	0.462	0.000
T47.3 Saline and osmotic laxatives	0.538	0.462	0.000
T47.2 Stimulant laxatives	0.538	0.462	0.000
T47.0 Histamine H(2)-receptor antagonists	0.538	0.462	0.000
T33-T35 Frostbite	0.537	0.463	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.537	0.463	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.536	0.463	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.524	0.465	0.010
G70 Myasthenia gravis and other myoneural disorders	0.533	0.467	0.000
S37 Injury of urinary and pelvic organs	0.532	0.468	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.532	0.468	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.531	0.468	0.000
F31.7 Bipolar affective disorder, currently in remission	0.530	0.470	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.530	0.470	0.000
J39.8 Other specified diseases of upper respiratory tract	0.000	0.471	0.529
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.528	0.472	0.000
E07 Other disorders of thyroid	0.002	0.472	0.525
G24.9 Dystonia, unspecified	0.527	0.473	0.000
S32.0 Fracture of lumbar vertebra	0.527	0.473	0.000
F45.8 Other somatoform disorders	0.527	0.473	0.000
J37.1 Chronic laryngotracheitis	0.000	0.474	0.526
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.526	0.474	0.000
Q51.3 Bicornate uterus	0.526	0.474	0.000
S19 Other and unspecified injuries of neck	0.525	0.475	0.000
T51.0 Ethanol	0.525	0.475	0.000
L10-L14 Bullous disorders	0.523	0.475	0.002
F68 Other disorders of adult personality and behaviour	0.524	0.475	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.524	0.475	0.000
F65 Disorders of sexual preference	0.524	0.475	0.000
F64 Gender identity disorders	0.524	0.475	0.000
F63 Habit and impulse disorders	0.524	0.475	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.524	0.475	0.000
F61 Mixed and other personality disorders	0.524	0.475	0.000
S90-S99 Injuries to the ankle and foot	0.523	0.477	0.000
T43.9 Psychotropic drug, unspecified	0.523	0.477	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.523	0.477	0.000
T43.6 Psychostimulants with abuse potential	0.523	0.477	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.523	0.477	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.523	0.477	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.522	0.477	0.001
Q35-Q37 Cleft lip and cleft palate	0.522	0.477	0.001
Q30-Q34 Congenital malformations of the respiratory system	0.522	0.477	0.001
J86 Pyothorax	0.000	0.480	0.520
Q82 Other congenital malformations of skin	0.519	0.481	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.519	0.481	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.518	0.482	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.518	0.482	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.518	0.482	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.518	0.482	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.518	0.482	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.518	0.482	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.518	0.482	0.000
T44.0 Anticholinesterase agents	0.518	0.482	0.000
J85 Abscess of lung and mediastinum	0.000	0.483	0.516
F99-F99 Unspecified mental disorder	0.516	0.484	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.516	0.484	0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.515	0.485	0.000
S36 Injury of intra-abdominal organs	0.515	0.485	0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.515	0.485	0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.515	0.485	0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.515	0.485	0.000
J00 Acute nasopharyngitis [common cold]	0.000	0.485	0.515
M07.36 Other psoriatic arthropathies (Lower leg)	0.511	0.485	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.514	0.486	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.514	0.486	0.000
T46.7 Peripheral vasodilators	0.514	0.486	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.514	0.486	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.514	0.486	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.514	0.486	0.000
T46.1 Calcium-channel blockers	0.514	0.486	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.514	0.486	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.486	0.514
J41.1 Mucopurulent chronic bronchitis	0.000	0.486	0.514
J41.0 Simple chronic bronchitis	0.000	0.486	0.514
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.487	0.513
Q54 Hypospadias	0.513	0.487	0.000
F44.5 Dissociative convulsions	0.512	0.488	0.000
S32.1 Fracture of sacrum	0.512	0.488	0.000
S10 Superficial injury of neck	0.511	0.489	0.000
T79-T79 Certain early complications of trauma	0.511	0.489	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.510	0.490	0.000
F30.8 Other manic episodes	0.510	0.490	0.000
F30.2 Mania with psychotic symptoms	0.510	0.490	0.000
F30.1 Mania without psychotic symptoms	0.510	0.490	0.000
G93 Other disorders of brain	0.509	0.491	0.000
F44.9 Dissociative [conversion] disorder, unspecified	0.508	0.491	0.000
M14 Arthropathies in other diseases classified elsewhere	0.341	0.491	0.167
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.492	0.508
Q21.1 Atrial septal defect	0.506	0.494	0.000
J01.8 Other acute sinusitis	0.000	0.494	0.506
J01.4 Acute pansinusitis	0.000	0.494	0.506
J01.3 Acute sphenoidal sinusitis	0.000	0.494	0.506
J01.2 Acute ethmoidal sinusitis	0.000	0.494	0.506
J01.1 Acute frontal sinusitis	0.000	0.494	0.506
J01.0 Acute maxillary sinusitis	0.000	0.494	0.506
M12 Other specific arthropathies	0.321	0.495	0.184
M09 Juvenile arthritis in diseases classified elsewhere	0.321	0.495	0.184
M08 Juvenile arthritis	0.321	0.495	0.184
G61 Inflammatory polyneuropathy	0.504	0.496	0.000
T50.8 Diagnostic agents	0.503	0.497	0.000
T50.7 Analeptics and opioid receptor antagonists	0.503	0.497	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.503	0.497	0.000
T50.5 Appetite depressants	0.503	0.497	0.000
T50.4 Drugs affecting uric acid metabolism	0.503	0.497	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.503	0.497	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.503	0.497	0.000
T50.1 Loop [high-ceiling] diuretics	0.503	0.497	0.000
T50.0 Mineralocorticoids and their antagonists	0.503	0.497	0.000
F32.1 Moderate depressive episode	0.502	0.498	0.000
Q18 Other congenital malformations of face and neck	0.500	0.499	0.001
F33.9 Recurrent depressive disorder, unspecified	0.500	0.499	0.000
Q21.0 Ventricular septal defect	0.500	0.500	0.000
E04 Other non-toxic goitre	0.001	0.500	0.498
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.499	0.501	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.498	0.501	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.000	0.503	0.496
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.503	0.496
J39.1 Other abscess of pharynx	0.000	0.503	0.496
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.503	0.496
J32.1 Chronic frontal sinusitis	0.000	0.504	0.496
J80 Adult respiratory distress syndrome	0.000	0.504	0.496
F33.8 Other recurrent depressive disorders	0.496	0.504	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.496	0.504	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.496	0.504	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.036	0.504	0.460
J05.1 Acute epiglottitis	0.000	0.507	0.493
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.493	0.507	0.000
Q83 Congenital malformations of breast	0.492	0.508	0.001
L50 Urticaria	0.491	0.508	0.001
G56.0 Carpal tunnel syndrome	0.492	0.508	0.000
L43 Lichen planus	0.491	0.508	0.001
F60.8 Other specific personality disorders	0.492	0.508	0.000
F60.7 Dependent personality disorder	0.492	0.508	0.000
F60.6 Anxious [avoidant] personality disorder	0.492	0.508	0.000
F60.5 Anankastic personality disorder	0.492	0.508	0.000
F60.4 Histrionic personality disorder	0.492	0.508	0.000
F60.2 Dissocial personality disorder	0.492	0.508	0.000
F60.1 Schizoid personality disorder	0.492	0.508	0.000
F60.0 Paranoid personality disorder	0.492	0.508	0.000
Q89 Other congenital malformations, not elsewhere classified	0.491	0.509	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.509	0.490
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.489	0.510	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.039	0.511	0.450
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.489	0.511	0.000
S39.8 Other specified injuries of abdomen, lower back and pelvis	0.489	0.511	0.000
Q76 Congenital malformations of spine and bony thorax	0.488	0.511	0.001
J04.0 Acute laryngitis	0.000	0.512	0.488
G51.0 Bell's palsy	0.486	0.514	0.000
E12 Malnutrition-related diabetes mellitus	0.011	0.515	0.474
M11 Other crystal arthropathies	0.310	0.515	0.175
F43 Reaction to severe stress, and adjustment disorders	0.485	0.515	0.000
L53 Other erythematous conditions	0.483	0.516	0.001
G70.0 Myasthenia gravis	0.484	0.516	0.000
G24.3 Spasmodic torticollis	0.484	0.516	0.000
E40-E46 Malnutrition	0.026	0.518	0.457
G23 Other degenerative diseases of basal ganglia	0.482	0.518	0.000
G21 Secondary Parkinsonism	0.482	0.518	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.482	0.518	0.000
G22 Parkinsonism in diseases classified elsewhere	0.482	0.518	0.000
J05.0 Acute obstructive laryngitis [croup]	0.000	0.518	0.481
G60 Hereditary and idiopathic neuropathy	0.481	0.519	0.000
M07.38 Other psoriatic arthropathies (Other)	0.476	0.519	0.005
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.476	0.519	0.005
M07.33 Other psoriatic arthropathies (Forearm)	0.476	0.519	0.005
M07.32 Other psoriatic arthropathies (Upper arm)	0.476	0.519	0.005
M07.31 Other psoriatic arthropathies (Shoulder region)	0.476	0.519	0.005
S40 Superficial injury of shoulder and upper arm	0.480	0.520	0.000
M06.3 Rheumatoid nodule	0.145	0.520	0.335
J04.2 Acute laryngotracheitis	0.000	0.521	0.479
J04.1 Acute tracheitis	0.000	0.521	0.479
Q53 Undescended testicle	0.479	0.521	0.001
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.478	0.522	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.478	0.522	0.000
T45.8 Other primarily systemic and haematological agents	0.478	0.522	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.478	0.522	0.000
T45.6 Fibrinolysis-affecting drugs	0.478	0.522	0.000
T45.5 Anticoagulants	0.478	0.522	0.000
T45.4 Iron and its compounds	0.478	0.522	0.000
T45.3 Enzymes, not elsewhere classified	0.478	0.522	0.000
T45.2 Vitamins, not elsewhere classified	0.478	0.522	0.000
J02 Acute pharyngitis	0.000	0.523	0.477
E06 Thyroiditis	0.002	0.524	0.473
J32.9 Chronic sinusitis, unspecified	0.000	0.525	0.475
G00-G09 Inflammatory diseases of the central nervous system	0.474	0.526	0.000
E07.9 Disorder of thyroid, unspecified	0.001	0.526	0.473
M05 Seropositive rheumatoid arthritis	0.241	0.527	0.232
J43 Emphysema	0.000	0.527	0.473
J35 Chronic diseases of tonsils and adenoids	0.000	0.528	0.471
G30-G32 Other degenerative diseases of the nervous system	0.469	0.531	0.000
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.469	0.531	0.000
S32.2 Fracture of coccyx	0.469	0.531	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.469	0.531	0.000
F34.1 Dysthymia	0.469	0.531	0.000
G58 Other mononeuropathies	0.469	0.531	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.468	0.532	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.467	0.533	0.001
Q55 Other congenital malformations of male genital organs	0.467	0.533	0.001
Q52 Other congenital malformations of female genitalia	0.467	0.533	0.001
G56.2 Lesion of ulnar nerve	0.467	0.533	0.000
L52 Erythema nodosum	0.465	0.534	0.001
J31.1 Chronic nasopharyngitis	0.000	0.535	0.465
M07.6 Other enteropathic arthropathies	0.385	0.535	0.080
M07.5 Arthropathy in ulcerative colitis	0.385	0.535	0.080
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.385	0.535	0.080
M07.2 Psoriatic spondylitis	0.385	0.535	0.080
M07.1 Arthritis mutilans	0.385	0.535	0.080
M07.0 Distal interphalangeal psoriatic arthropathy	0.385	0.535	0.080
J93 Pneumothorax	0.000	0.535	0.465
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.464	0.536	0.000
G50 Disorders of trigeminal nerve	0.463	0.537	0.000
M60-M63 Disorders of muscles	0.358	0.538	0.104
E14 Unspecified diabetes mellitus	0.006	0.538	0.456
Q67 Congenital musculoskeletal deformities of head, face, spine and chest	0.461	0.539	0.001
J32.8 Other chronic sinusitis	0.000	0.539	0.461
S70-S79 Injuries to the hip and thigh	0.461	0.539	0.000
J31.2 Chronic pharyngitis	0.000	0.539	0.460
J32.2 Chronic ethmoidal sinusitis	0.000	0.540	0.460
F44.8 Other dissociative [conversion] disorders	0.459	0.541	0.000
F44.7 Mixed dissociative [conversion] disorders	0.459	0.541	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.459	0.541	0.000
F44.4 Dissociative motor disorders	0.459	0.541	0.000
F44.3 Trance and possession disorders	0.459	0.541	0.000
F44.2 Dissociative stupor	0.459	0.541	0.000
F44.1 Dissociative fugue	0.459	0.541	0.000
F44.0 Dissociative amnesia	0.459	0.541	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.459	0.541	0.000
S32.3 Fracture of ilium	0.459	0.541	0.000
E03.8 Other specified hypothyroidism	0.001	0.541	0.458
J06 Acute upper respiratory infections of multiple and unspecified sites	0.000	0.542	0.458
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.024	0.542	0.434
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.003	0.542	0.455
E00 Congenital iodine-deficiency syndrome	0.003	0.542	0.455
E02 Subclinical iodine-deficiency hypothyroidism	0.003	0.542	0.455
G51.3 Clonic hemifacial spasm	0.458	0.542	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.455	0.545	0.001
S17 Crushing injury of neck	0.454	0.546	0.000
S15 Injury of blood vessels at neck level	0.454	0.546	0.000
S14 Injury of nerves and spinal cord at neck level	0.454	0.546	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations